Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
about
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.COX-2 mRNA expression in esophageal squamous cell carcinoma (ESCC) and effect by NSAID.Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.
P2860
Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
@en
type
label
Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
@en
prefLabel
Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
@en
P2093
P1476
Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
@en
P2093
Barbara J Jackson
Dale R Riggs
David W McFadden
Linda Vona-Davis
P304
P356
10.1016/J.JSS.2004.03.014
P577
2004-06-01T00:00:00Z